Eligibility criteria
Condition
Diabetic Neuropathies
Sex
Females and Males
Age
51 + years
Inclusion criteria
Show details
- Patients with stable Diabetes Mellitus 1 or 2
- Clinical diagnosis of distal symmetric polyneuropathy with a minimum duration of 8
weeks
- No clinically significant motor deficits
- Pain described according to at least one of the following clinical manifestations:
burning, cramps or twinges, thermal or mechanical alodinea
Exclusion criteria
Show details
- Treatment with any medication that may interfere with the assessment of gabapentin
during the study or within 7 days of the adminstration of gabapentin
- Specific systemic diseases or other medical conditions that would interfere with the
assessment of gabapentin therapeutic response or safety